MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 22 May 2017 |
| Author/s |
author: Javier Cortes Hope Rugo Denise A Yardley Sara M Tolaney Joyce O'Shaughnessy |
| Publication date | May 22, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |